...
首页> 外文期刊>International immunopharmacology >SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.
【24h】

SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.

机译:SM934是一种青蒿素的水溶性衍生物,可在体内和体外发挥免疫抑制功能。

获取原文
获取原文并翻译 | 示例

摘要

In the present study, we investigated the immunosuppressive effects and underlying mechanisms of beta-aminoarteether maleate (SM934), a derivative of artemisinin, against T cell activation in vitro and in vivo. In vitro, SM934 significantly inhibited the proliferation of splenocytes induced by concanavalin A (Con A), lipopolysaccharide (LPS), mixed lymphocyte reaction (MLR), and anti-CD3 plus anti-CD28 (anti-CD3/28). SM934 significantly inhibited interferon (IFN)-gamma production and CD4(+) T cell division stimulated by anti-CD3/28. SM934 also promoted apoptosis of CD69(+) population in CD4(+) T cells stimulated by anti-CD3/28. Furthermore, SM934 inhibited interleukin (IL)-2 mediated proliferation and survival through blocking Akt phosphorylation in activated T cells. In ovalbumin (OVA)-immunized mice, oral administration of SM934 suppressed OVA-specific T cell proliferation and IFN-gamma production. SM934 treatment also significantly inhibited the sheep red blood cell (SRBC)-induced delayed type hypersensitivity (DTH) reactions in mice. Taken together, SM934 showed potent immunosuppressive activities in vitro and in vivo. Our results demonstrated that SM934 might be a potential therapeutic agent for immune-related diseases.
机译:在本研究中,我们研究了青蒿素的衍生物-马来酸β-氨基arteether马来酸酯(SM934)在体外和体内对T细胞活化的免疫抑制作用和潜在机制。在体外,SM934显着抑制伴刀豆球蛋白A(Con A),脂多糖(LPS),混合淋巴细胞反应(MLR)和抗CD3加抗CD28(抗CD3 / 28)诱导的脾细胞增殖。 SM934显着抑制抗CD3 / 28刺激的干扰素(IFN)-γ产生和CD4(+)T细胞分裂。 SM934还可以促进抗CD3 / 28刺激的CD4(+)T细胞中CD69(+)群体的凋亡。此外,SM934通过阻断活化T细胞中的Akt磷酸化抑制白介素(IL)-2介导的增殖和存活。在卵清蛋白(OVA)免疫的小鼠中,口服SM934可抑制OVA特异性T细胞增殖和IFN-γ产生。 SM934处理还可以显着抑制绵羊红细胞(SRBC)引起的小鼠迟发型超敏反应(DTH)反应。综上所述,SM934在体外和体内均显示出强大的免疫抑制活性。我们的结果表明,SM934可能是免疫相关疾病的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号